The negative outlook accompanied an affirmed “A” rating on a series of revenue bonds, the rating group said.
“The negative outlook further reflects TidalHealth’s declining unrestricted reserves, weakening balance sheet metrics and limited flexibility at the current rating level,” said Chloe Pickett, S&P Global Ratings credit analyst.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
